Join the club for FREE to access the whole archive and other member benefits.

Yi Zheng

Director of Experimental Hematology and Cancer Biology, Co-Director at Cancer and Blood Diseases Institute

The research activities of Dr. Yi Zheng’s laboratory focus on studies of the physiological and pathological function and the mechanism of regulation of Rho family GTP-binding proteins. 

The Rho GTPases are a class of intracellular signal transducers that play important roles in the regulation of diverse cellular activities including actin cytoskeleton reorganization, transcription activation, and DNA synthesis. Like Ras, mutation, overexpression or disruption of the normal mode of regulation of these GTP-binding and GTP-hydrolyzing molecular switches may lead to cellular transformation, morphological changes, and developmental disorders. 

Co-founder of Mogling Bio.

Visit website: https://www.cincinnatichildrens.org/research/divisions/e/ex-hem/labs/zheng

See also: Health Organisation Cincinnati Children’s Hospital Medical Center - Academic pediatric acute care children's hospital

Details last updated 28-Oct-2022

Yi Zheng is also referenced in the following:

Mogling Bio

Biopharmaceutical company developing new treatments for rejuvenating old stem cells

Yi Zheng News

Stem cell biotech MoglinBio secures seed investment

Stem cell biotech MoglinBio secures seed investment

KIZOO Technology Ventures - 26-Oct-2022

Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity